| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | 76.4 | ¤1,196,229 | US |
| AZN.GB | AstraZeneca PLC | 62.5 | ¤262,042 | GB |
| AMGN | Amgen Inc. | 67.6 | ¤236,981 | US |
| NOVO.B.DK | Novo Nordisk A/S Class B | 68.5 | ¤173,870 | DK |
| ISRG | Intuitive Surgical, Inc. | 61.7 | ¤151,245 | US |
| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| 4151.JP | Kyowa Kirin Co., Ltd. | 65.3 | ¤7,936 | JP |
| ALK.B.DK | ALK-abello A/S Class B | 67.0 | ¤8,090 | DK |
| TGTX | TG Therapeutics, Inc. | 62.0 | ¤8,143 | US |
| PTGX | Protagonist Therapeutics, Inc. | 67.4 | ¤8,935 | US |
| KRYS | Krystal Biotech, Inc. | 69.8 | ¤9,536 | US |
| Symbol | Name | Grade | Times* | Country |
|---|---|---|---|---|
| NOVO.B.DK | Novo Nordisk A/S Class B | 68.5 | 39 | DK |
| AMGN | Amgen Inc. | 67.6 | 32 | US |
| ISRG | Intuitive Surgical, Inc. | 61.7 | 28 | US |
| RMD | ResMed Inc. | 65.3 | 26 | US |
| REGN | Regeneron Pharmaceuticals, Inc. | 59.4 | 25 | US |
| LLY | Eli Lilly and Company | 76.4 | 24 | US |
| 4507.JP | Shionogi & Co., Ltd. | 71.5 | 23 | JP |
| BMY | Bristol-Myers Squibb Company | 67.0 | 23 | US |
| 4519.JP | Chugai Pharmaceutical Co., Ltd. | 65.4 | 22 | JP |
| 7741.JP | HOYA CORPORATION | 75.2 | 22 | JP |
| Average Market Cap | ¤70,175 |
| Median Market Cap | ¤24,168 |
| Avg. 3 Mo. Dollar Vol. | ¤316,736,433 |
| Avg. 3 Mo. Trading Vol. | 2,331,940 |
| Last Rebalance Date | 09/21/2026 |
| Companies Replaced | 11 |
| Biggest Industry Increase | Managed Health Care |
| Biggest Industry Decrease | Pharmaceuticals: Major |
| Trailing P/E Ratio (12 Mo.) | 23.8 |
| Forward P/E Ratio (12 Mo.) | 20.2 |
| Price/Book Ratio | 5.3 |
| Avg. Revenue Chg. - 3 Yr | 42.1% |
| Avg. Op. Income Chg. - 3 Yr. | 83.8% |
| Avg. EPS Growth - 3 Yr. | 23.1% |
| Avg. EPS Growth - 1 Yr. | 15.9% |
| Avg. Operating Margin | 26.9% |
| Avg. LT Debt to Total Capital | 23.3% |
| Avg. Return on Equity | 22.1% |
| Dividend Yield | 0.1% |
| Developed Markets (ex-Australia) Health Care Index | 68.37 |
| United States Of America | 62.0% |
| Japan | 16.0% |
| Korea, Republic Of | 4.0% |
| Denmark | 4.0% |
| Finland | 2.0% |
| France | 2.0% |
| United Kingdom | 2.0% |
| Ireland | 2.0% |
| Netherlands | 2.0% |
| New Zealand | 2.0% |
| Belgium | 2.0% |
